Sunshine Biopharma Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sunshine Biopharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q4 2024.
  • Sunshine Biopharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$2.16M, a 72.7% decline year-over-year.
  • Sunshine Biopharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$5.13M, a 13.9% decline year-over-year.
  • Sunshine Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$5.13M, a 13.9% decline from 2023.
  • Sunshine Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.51M, a 83.2% increase from 2022.
  • Sunshine Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.7M, a 115% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$5.13M -$2.16M -$908K -72.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-01
Q3 2024 -$4.23M -$1.2M -$546K -83.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$3.68M -$494K +$408K +45.2% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 -$4.09M -$1.28M +$419K +24.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$4.51M -$1.25M +$22.3M +94.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-01
Q3 2023 -$26.8M -$651K +$806K +55.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$27.6M -$902K -$363K -67.4% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q1 2023 -$27.2M -$1.7M -$466K -37.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$26.7M -$23.5M -$24.2M -3624% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$2.57M -$1.46M +$2.58M +63.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$5.15M -$539K +$2.34M +81.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$7.49M -$1.24M +$4.95M +80% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$12.4M $667K +$1.75M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-04
Q3 2021 -$14.2M -$4.04M -$3.34M -478% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$10.8M -$2.88M -$1.97M -217% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$8.87M -$6.19M -$6.09M -6462% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$2.78M -$1.08M -$687K -173% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$2.1M -$699K -$348K -99.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1.75M -$907K -$197K -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$1.55M -$94.3K +$108K +53.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$1.66M -$397K -$58K -17.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$1.6M -$350K +$557K +61.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$2.16M -$711K -$66.6K -10.3% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$2.09M -$203K +$63.1K +23.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$2.16M -$339K -$127K -60.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-01
Q3 2018 -$2.03M -$908K -$760K -515% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$1.27M -$644K -$159K -32.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$1.11M -$266K -$69.9K -35.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$1.04M -$211K +$913K +81.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-12
Q3 2017 -$1.95M -$148K +$1.44M +90.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$3.39M -$485K -$4.13K -0.86% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
Q1 2017 -$3.39M -$196K +$110K +35.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-22
Q4 2016 -$3.5M -$1.12M -$486K -76.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$3.01M -$1.59M -$1.38M -682% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-15
Q2 2016 -$1.63M -$481K +$36.2K +7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$1.66M -$305K -$10.9K -3.71% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$1.65M -$638K -$252K -65.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$1.4M -$203K +$78K +27.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.48M -$518K +$248K +32.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 -$1.73M -$294K +$207K +41.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.93M -$387K +$297K +43.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$2.23M -$281K -$103K -57.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$2.13M -$766K -$613K -400% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$1.52M -$501K +$976K +66.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$2.49M -$683K -$495K -262% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$2M -$178K +$199K +52.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$2.2M -$153K -$49.9K -48.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$2.15M -$1.48M -$1.44M -3655% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$708K -$189K +$185K +49.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 -$893K -$377K -$260K -224% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 -$633K -$103K -$86.6K -525% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-08
Q1 2012 -$546K -$39.3K +$9.88K +20.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$556K -$374K -$2.87M -115% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-19
Q3 2011 $2.31M -$116K +$44K +27.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $2.27M -$16.5K +$1.57M +99% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $699K -$49.2K +$1.24M +96.2% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 -$537K $2.5M Oct 1, 2010 Dec 31, 2010 10-K 2014-03-19
Q3 2010 -$160K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$1.59M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
Q1 2010 -$1.29M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.